In other studies, it was shown that MCC950 could effectively alleviate diabetes-induced renal damage by inhibiting the NLRP3/Caspase-1 pathway, which may be a potential therapeutic strategy for preventing the progression of diabetic nephropathy [39]. This evidence concerns the gene CASP1 and diabetic kidney disease.